Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.
about
Biomarkers and recent advances in the management and therapy of sickle cell diseaseDysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaStroke in patients with sickle cell disease.Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice.microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease.Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease.Peroxisome proliferator-activated receptor-α-mediated transcription of miR-199a2 attenuates endothelin-1 expression via hypoxia-inducible factor-1αGlutamine supplementation alleviates vasculopathy and corrects metabolic profile in an in vivo model of endothelial cell dysfunctionClinical assay of four thiol amino acid redox couples by LC-MS/MS: utility in thalassemiaClinical biomarkers in sickle cell disease.Role of aminotransferases in glutamate metabolism of human erythrocytes.MicroRNA 648 Targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5.2D DIGE based proteomics study of erythrocyte cytosol in sickle cell disease: altered proteostasis and oxidative stress.Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsPleiotropic effects of intravascular haemolysis on vascular homeostasis.Glutamine supplementation in sick children: is it beneficial?Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disordersPhase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell DiseasePossible links between sickle cell crisis and pentavalent antimony.N-acetylcysteine reduces oxidative stress in sickle cell patientsA nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial.Nonhematopoietic Nrf2 dominantly impedes adult progression of sickle cell anemia in mice.A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodesNovel small molecule therapeutics for sickle cell disease: nitric oxide, carbon monoxide, nitrite, and apolipoprotein A-I.Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapySickle cell anemia and vascular dysfunction: the nitric oxide connection.Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.Biomarkers in sickle cell disease.Role of oxidative stress in the pathogenesis of sickle cell disease.Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.Emerging drugs for sickle cell anemia.Triterpenoid inducers of Nrf2 signaling as potential therapeutic agents in sickle cell disease: a review.Mortality, asthma, smoking and acute chest syndrome in young adults with sickle cell disease.A new metabolomic assay to examine inflammation and redox pathways following LPS challenge.Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation.Pathophisiology of sickle cell disease and new drugs for the treatment.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension associated with hemolytic anemia.The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology.Pulmonary hypertension in hemolytic anemiasBrain neurochemical and hemodynamic findings in the NY1DD mouse model of mild sickle cell disease.
P2860
Q28082462-018A6713-BDF1-4C04-A86A-8BAE52D05F57Q28395387-A9CF0B4A-ADE6-413E-8444-BB2CFA0233ADQ30650303-ED40A455-7484-4B54-A5BB-4446F11DD0BEQ33686611-BCA01794-0BA0-47B8-946C-B928A84281CAQ34360379-828C80F8-9654-4609-8CAA-52DFBDCD6F83Q34639791-1C82EF8B-AD8F-4A7C-A3AF-17150288B8B7Q34774521-11F93CC5-E9BB-407E-BAA5-17D0A142E6E8Q34775724-BAB6924E-AA23-4266-B586-A099DD1C0B70Q34798959-04B448A0-28F9-4D97-A060-F6991CC28B6EQ34800466-B07EA49F-9F73-401A-AB4A-365359F072DCQ34843666-2D1DB797-D9A1-4C5E-A19B-A74E093F78EBQ34846466-2F98536A-6FAF-47CE-BB88-58415E150E74Q34986273-AEF97777-358A-4F34-B11B-D96FD72185BAQ34992760-35C45AB3-F4B1-4AAF-B34F-3F69CA8B62ACQ35535204-AC0EDCF8-1E77-4F57-A3E3-15040020D834Q35585329-2CF7D1E0-71B4-4559-AA1B-E29E1531F5B9Q35590733-5B4CF644-352F-4990-87D9-4301BE757B22Q35987429-67A61F97-DB36-4095-A6A0-0BCD04223ECDQ36005847-AA1F32D8-8B3C-46ED-AFB6-1AC70CAE3E90Q36010842-7C2CE484-D241-4414-B3AA-6517F33A42FBQ36117465-798A142F-5686-4E25-ABC0-550B83FA2541Q36870605-970E4784-3B58-44EE-BEB7-5266A8362C47Q37144863-30AA1679-37F8-449A-86ED-F4DFEB7FB497Q37346719-881285B4-38BA-43A3-8D52-9BC2F7ACD615Q37415993-48366F90-8B15-4EBC-BFC0-3A205F80FCA4Q37767680-88D5670F-17BE-45EF-8BD0-583431A816A9Q37872265-CC7D43F9-CEC6-4231-93E3-DC43A7258868Q37961814-538718CB-C58C-4F75-AC33-E9500DC04DB2Q37963311-A809C70D-0FC2-4C1D-9E08-A6ADE798632AQ38115527-2DB2AF6B-AC8B-4443-989E-13F89B0C16BEQ38272226-26F6AA69-72CA-4E7E-8D06-D6113029D0CCQ38289589-7B0D4F3C-8DB1-4B35-AE70-061A0C2B433CQ39141859-BB7CB4CD-2201-461D-8806-A81644DF1FE3Q39266063-BF77DABD-3E67-4006-ACEB-019953AA4A4FQ39632862-52ABE12B-737F-493C-9C52-D77121497DE8Q41777376-F26DDE4B-7952-401C-A64A-59BFB3964B6DQ41975944-D020C8F7-9D0E-4E83-874D-5B5027A30264Q42349186-48384C15-95A7-422E-A394-E4ED607903B5Q42415504-A260E13B-2777-4C19-AE7B-10B3176D767CQ42505511-3A281FF1-5DFC-44A1-87FA-6C5F23D282A7
P2860
Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Erythrocyte glutamine depletio ...... ension in sickle cell disease.
@ast
Erythrocyte glutamine depletio ...... ension in sickle cell disease.
@en
type
label
Erythrocyte glutamine depletio ...... ension in sickle cell disease.
@ast
Erythrocyte glutamine depletio ...... ension in sickle cell disease.
@en
prefLabel
Erythrocyte glutamine depletio ...... ension in sickle cell disease.
@ast
Erythrocyte glutamine depletio ...... ension in sickle cell disease.
@en
P2093
P2860
P50
P1433
P1476
Erythrocyte glutamine depletio ...... ension in sickle cell disease.
@en
P2093
Bruce Ames
Claudia R Morris
D Anton Bland
Frans A Kuypers
Jung H Suh
Mark Shigenaga
Sandra Larkin
Ward Hagar
P2860
P304
P356
10.1182/BLOOD-2007-04-081703
P407
P577
2007-09-11T00:00:00Z